Filing Flows › DataMeds AI (MEDS) › Q1 2025
DataMeds AI (MEDS) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 12, 2025
DataMeds AI (MEDS) reported revenue of $10.9M for the first quarter 2025 (Q1 2025) and -12% from the quarter before. Operating margin was -288.6%, net loss $32.4M (298.5% of revenue).
DataMeds AI, Q1 2025: revenue $10.9M, operating margin -288.6%, net loss $32.4M, operating cash flow −$1.3M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $10.9M | -12% | — |
| Operating profit | −$31.3M | — | — |
| Net earnings | −$32.4M | — | — |
| Operating cash flow | −$1.3M | — | — |
What changed
Revenue was $10.9M in Q1 2025, down 12% from the previous quarter. Product was the largest line at 98% of revenue.
Gross margin was 6.4%. Operating costs exceeded revenue by $31.3M, an operating margin of -288.6%. The quarter ended with a net loss of $32.4M, wider than the previous quarter's $4.3M loss.
Operating cash flow was −$1.3M. Non-cash charges added back $803K of depreciation and amortization and $27.8M of share-based compensation. Working capital and other items added $2.5M.
Questions
What was DataMeds AI's revenue in the first quarter 2025?
DataMeds AI (MEDS) reported revenue of $10.9M for the first quarter 2025 (Q1 2025) and -12% from the quarter before.
Was DataMeds AI profitable in the first quarter 2025?
Operating loss was $31.3M (-288.6% of revenue) and net loss $32.4M.
Source: DataMeds AI 10-Q on SEC EDGAR.